The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Guidewire Use in Nasotracheal Intubation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05937516
Recruitment Status : Completed
First Posted : July 10, 2023
Last Update Posted : July 10, 2023
Sponsor:
Information provided by (Responsible Party):
Asım Esen, Bezmialem Vakif University

Brief Summary:
During nasotracheal intubation, nasopharyngeal trauma and associated bleeding may occur. The investigators think that some of this bleeding is due to trauma to the posterior wall of the nasopharynx. The investigators designed this study, thinking that if nasopharyngeal posterior wall trauma can be prevented, some of these bleedings can be prevented.

Condition or disease Intervention/treatment Phase
Epistaxis Nosebleed Pharyngeal Bleeding Device: Nasotracheal intubation with conventionally Device: Nasotracheal intubation with angled ETT using guidewire Not Applicable

Detailed Description:

Nasotracheal intubation (NTI) is a frequently used airway management method in pedodontic dental treatments performed under general anesthesia. However, nasopharyngeal trauma and associated bleeding are common during conventional NTI. In this study, the investigators aimed to examine the effect of angling the end of the endotracheal tube (ETT) by placing a guide wire inside the ETT on nasopharyngeal bleeding.

The patients included in the study were randomized into two groups. In the control group (Group C), NTI will be done conventionally. In the study group (Group S), a guide wire will be inserted into the ETT before intubation and angled 100-120 degrees to the distal end (in the shape of a hockey stick). The angulation will not be sharp but slightly curved and the apex of the angulation will be 2.5-3 cm proximal from the distal end. The ETT will be positioned perpendicular to the face and inserted into the nostril. After the angled part of the ETT passes through the nostrils, it will be directed to caudally according to the angle given to the tip of the ETT. Meanwhile, the ETT will be moved as a whole to prevent the ETT tip from contacting the posterior wall of the nasopharynx. When the ETT tip reaches the oropharynx, the guidewire will be removed and the rest of the intubation will be completed as in the conventional method.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 90 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Masking Description: After intubation was completed, bleeding was evaluated by the other investigator who did not know the patient's group.
Primary Purpose: Diagnostic
Official Title: Guidewire Use for Nasopharyngeal Passage in Pediatric Nasotracheal Intubation: A Randomized Prospective Study
Actual Study Start Date : March 15, 2023
Actual Primary Completion Date : April 20, 2023
Actual Study Completion Date : April 20, 2023

Arm Intervention/treatment
Sham Comparator: Control Group
Nasotracheal intubation will be applied conventionally to patients in this group.
Device: Nasotracheal intubation with conventionally
Nasotracheal intubation will be applied conventionally to patients in this group.

Active Comparator: Study Group
In the study group (Group S), a guide wire will be inserted into the ETT before intubation and angled 100-120 degrees to the distal end (in the shape of a hockey stick). The angulation will not be sharp but slightly curved and the apex of the angulation will be 2.5-3 cm proximal from the distal end. The ETT will be positioned perpendicular to the face and inserted into the nostril. After the angled part of the ETT passes through the nostrils, it will be directed to caudally according to the angle given to the tip of the ETT. Meanwhile, the ETT will be moved as a whole to prevent the ETT tip from contacting the posterior wall of the nasopharynx. When the ETT tip reaches the oropharynx, the guidewire will be removed and the rest of the intubation will be completed as in the conventional method.
Device: Nasotracheal intubation with angled ETT using guidewire
a guide wire will be inserted into the ETT before intubation and angled 100-120 degrees to the distal end (in the shape of a hockey stick). The angulation will not be sharp but slightly curved and the apex of the angulation will be 2.5-3 cm proximal from the distal end. The ETT will be positioned perpendicular to the face and inserted into the nostril. After the angled part of the ETT passes through the nostrils, it will be directed to caudally according to the angle given to the tip of the ETT. Meanwhile, the ETT will be moved as a whole to prevent the ETT tip from contacting the posterior wall of the nasopharynx. When the ETT tip reaches the oropharynx, the guidewire will be removed and the rest of the intubation will be completed as in the conventional method.




Primary Outcome Measures :
  1. Presence of blood in oropharynx or on the endotracheal tube [ Time Frame: In the first minute after intubation ]
    The presence of blood in the oropharynx or endotracheal tube will be defined by assessing it on a scale. (0 = no blood, 2 = mild, that is, dye-like blood on the endotracheal tube, 3 = severe, that is, obvious blood in the oropharynx).

  2. Presence of blood in oropharynx or on the endotracheal tube [ Time Frame: In the fifth minute after intubation ]
    The presence of blood in the oropharynx or endotracheal tube will be defined by assessing it on a scale. (0 = no blood, 2 = mild, that is, dye-like blood on the endotracheal tube, 3 = severe, that is, obvious blood in the oropharynx).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   2 Years to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • 2-12 years old
  • American Society of Anesthesiologists I-III
  • Patients with elective dental surgery
  • Patients whose parents have accepted informed consent forms
  • Patients without previous nasopharyngeal anomalies
  • Patients without previous nasopharyngeal surgeries
  • Patients without upper airway infections

Exclusion Criteria:

  • Under 2 or over 12 years old
  • Emergency surgeries
  • Patients whose parents have not accepted informed consent forms
  • Patients with previous nasopharyngeal anomalies
  • Patients with previous nasopharyngeal surgeries
  • Patients with upper airway infections

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05937516


Locations
Layout table for location information
Turkey
Bezmialem Vakif University, Faculty of Medicine
Fatih, Istanbul, Turkey, 34093
Sponsors and Collaborators
Bezmialem Vakif University
Investigators
Layout table for investigator information
Principal Investigator: asim esen, Asst Prof Bezmialem Vakif University, Faculty of Medicine
Layout table for additonal information
Responsible Party: Asım Esen, Assistant Professor ASIM ESEN, Bezmialem Vakif University
ClinicalTrials.gov Identifier: NCT05937516    
Other Study ID Numbers: a.esen001
First Posted: July 10, 2023    Key Record Dates
Last Update Posted: July 10, 2023
Last Verified: July 2023

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Asım Esen, Bezmialem Vakif University:
Airway management
Intubation complication
Nasotracheal intubation
Nasal bleeding
Additional relevant MeSH terms:
Layout table for MeSH terms
Epistaxis
Hemorrhage
Pathologic Processes
Nose Diseases
Respiratory Tract Diseases
Otorhinolaryngologic Diseases
Signs and Symptoms, Respiratory